To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Charlesbank’s investment in Aptean brings company’s valuation to $2bn
TA is set to make 3.5x its equity on the stake sale to Charlesbank, a source told PE Hub.
